Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of inherited metabolic disease"
DOI: 10.1002/jimd.12489
Abstract: 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential cofactor for aromatic L-amino acid hydroxylases, including tyrosine hydroxylase (TH), alkylglycerol monooxygenase and three types of nitric oxide synthases (NOS). Sepiapterin reductase (SPR) catalyzes the third step of BH4 biosynthesis.…
read more here.
Keywords:
hypofunction sympathetic;
gene disrupted;
mice;
priapism ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Protoplasma"
DOI: 10.1007/s00709-021-01632-2
Abstract: Hepatocellular carcinoma (HCC) is one of the most common cancers associated with high mortality rate. Understanding of events leading to HCC pathophysiology is essential for its better management. We earlier reported development of a novel…
read more here.
Keywords:
protein;
regulator protein;
hepatocellular carcinoma;
sepiapterin reductase ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "ACS Omega"
DOI: 10.1021/acsomega.9b01228
Abstract: Tetrahydrobiopterin (BH4) is a cofactor in the production of various signaling molecules including nitric oxide, dopamine, adrenaline, and noradrenaline. BH4 levels are critical for processes associated with cardiovascular function, inflammation, mood, pain, and neurotransmission. Increasing…
read more here.
Keywords:
bh4;
bh4 pathway;
pain;
sepiapterin reductase ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Medicinal Chemistry"
DOI: 10.2210/pdb6i6p/pdb
Abstract: Genome-wide-association studies in chronic low back pain patients identified sepiapterin reductase as a high interest target for developing new analgesics. Here we used 19F NMR fragment screening for the discovery of novel, ligand-efficient SPR inhibitors.…
read more here.
Keywords:
fragment based;
discovery novel;
sepiapterin reductase;
based discovery ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1173599
Abstract: The development of novel analgesics for chronic pain in the last 2 decades has proven virtually intractable, typically failing due to lack of efficacy and dose-limiting side effects. Identified through unbiased gene expression profiling experiments…
read more here.
Keywords:
inhibition;
bh4;
chronic pain;
pain ... See more keywords